France and The Global Fund
The Global Fund, a key player in the fight against the three pandemics
In the year 2000, it seemed that nothing could stop the AIDS, tuberculosis and malaria pandemics. In response to this crisis, the international community reacted and created The Global Fund, an innovative partnership that mobilizes governments, civil society, the private sector and people affected by the diseases around a common goal: to end the three diseases. This partnership model was designed to promote innovative financing solutions and to strategically invest in effective programs. More than 27 million lives have been saved thanks to the Global Fund since 2002. The Global Fund's 2017-2022 strategy was developed in consultation with its partners and people affected by the diseases to enhance the impact of its grants.
The Global Fund is now the largest international donor in the fight against the three pandemics in developing countries, accounting for 20% of AIDS, 69% of tuberculosis and 65% of malaria funding.
This collective initiative has increased access to health care for communities most affected by the three diseases. Since its inception in 2002, the Global Fund partnership has had a significant impact: in countries where it invests, the number of HIV, TB and malaria related deaths has fallen by a third.
In 2019, the Global Fund Results Report counted, in the countries in which the Global Fund invests
- HIV/AIDS: 18.9 million people on antiretroviral treatment
- Malaria: 131 million mosquito nets distributed worldwide
- Tuberculosis: 5.9 million people treated for TB
These impressive results have helped strengthen local health systems and revitalize entire communities, both socially and economically.
In order to maintain the results achieved so far and to bring about further progress, the Global Fund's 2017-2022 strategy addresses emerging global health challenges. This multi-year roadmap is the result of a comprehensive consultative process with public and private partners and people affected by the three diseases. It aims to maximize the impact of its investments so that the response to the pandemics globally and at country level is inclusive, effective and sustainable. The Global Fund strategy contributes to and is fully aligned with the Sustainable Development Goals. Global Fund grants will greatly help countries to achieve Goal 3, and in particular the related target: to end the AIDS, tuberculosis and malaria epidemics by 2030.
Executive Director of the Global Fund , 2018 May
"As one of the founding partners of the Global Fund, France has a tremendous sense of responsibility and commitment to global health"
France supported the creation of the Global Fund in 2002 and remains one of its main political and financial support partners - for the 2017-2019 period France has contributed 360 million Euros per year. For the new 2020-2022 cycle, France has further strengthened its commitment to the Global Fund by announcing at the Lyon Replenishment Conference in October 2019 a 20% increase in its contribution.
Due to the level of financial support it provides, France is a full voting member on the Board of the Global Fund and sits on two of the three Standing Committees responsible for planning and monitoring the board's work (Strategy Committee and Audit and Finance Committee). France champions the founding values of the Global Fund on these platforms: the role of affected communities and civil society in the development and implementation of programs, fragile countries and key populations, a human rights approach. France is represented by 35 national coordinating bodies and acts through its regional advisers on global health and its diplomatic network in the countries receiving grants. France actively contributes to the Global Fund's strategic direction and evolution.